Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Bicycle Therapeutics plc (BCYC)

96 + Investors. Track Smart Money conviction in BCYC. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -14
Streak
1Q ▼
Buyers last Q
56%

Smart Money Signals — BCYC

Based on 96 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their BCYC positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 86% of 3.0Y peak

86% of all-time peak
96 funds currently hold this stock — 86% of the 3.0-year high of 111 funds (reached 2025 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding BCYC is almost the same as a year ago (+3 funds, +3% change). No significant rush to buy or sell — institutional backing is holding steady.
🟡

Slight buying edge — 56% buying

58 buying45 selling
Last quarter: 58 funds bought or added vs 45 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-8 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 31 → 9 → 23 → 15. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

41% of holders stayed for 2+ years

■ 41% conviction (2yr+) ■ 40% medium ■ 20% new
39 out of 96 hedge funds have held BCYC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -4%, value -41%

Value
-40%
Shares
-4%
Last quarter: funds added -4% more shares while total portfolio value only changed -41%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~15 new funds/quarter

14 → 31 → 9 → 23 → 15 new funds/Q
New funds entering each quarter: 31 → 9 → 23 → 15. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 56% veterans vs 24% newcomers

■ 56% veterans ■ 20% 1-2yr ■ 24% new
Entry-cohort mix of 101 holders: 57 (56%) are 2+ year veterans, 20 entered 1–2 years ago, and 24 (24%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 11% AUM from top-100

11% from top-100 AUM funds
23 of 96 holders rank in the top 100 by AUM, but together hold only 11% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
2.8
out of 10
Low Exit Risk
Exit risk score 2.8/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — BCYC

In 2026 Q1, 58 hedge funds were net buyers of BCYC (15 opened a new position, 43 added to an existing one), while 45 reduced or exited (16 trimmed, 29 sold completely) — a 56% buyer ratio, indicating a slight buying edge. Net fund flow last quarter: -14 funds (more exits than new entries). Total institutional holders: 96.

Hedge Fund Ownership: BCYC

How many hedge funds hold BCYC — quarterly history vs. share price
Quarterly hedge fund ownership of BCYC vs. share price

Market Analysis: BCYC

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: BCYC

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Bicycle Therapeutics plc (BCYC) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much BCYC has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 80d ago
BCYC
nan%
XLV
+2.1%

BCYC outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 35d ago
BCYC
nan%
XLV
+3.2%

Since the filing became public, BCYC outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 1 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
1.4
/ 10
conviction
Hedge Fund Positioning: BCYC
96 + Investors

Track Smart Money conviction in BCYC. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 96 110 -12.73%
13F Shares 38M 40M -4.49%
Total Value $162M $272M -40.55%
New Positions 15 23 -8
Increased Positions 42 35 +7
Closed Positions 29 13 +16
Reduced Positions 15 29 -14
Total Calls 2 4 -50.0%
Total Puts 3 3 -
PUT/CALL Ratio 1.5 0.75 Bearish

Statistics: BCYC

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

96 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in BCYC. Verified SEC 13F-HR filings.

QUARTER:
Top 25 BCYC holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Fcpm III Services B.V. 2.23% 3,468,430 $16.1M
2 Birchview Capital, LP 1.22% 463,599 $2.2M
3 GSK plc 1.18% 1,529,561 $7.1M
4 Rangeley Capital, LLC 1.05% 232,260 $1.1M
5 Flax Pond Capital, LLC 0.66% 176,136 $817K
6 Peapod Lane Capital LLC 0.45% 121,106 $550K
7 Long Focus Capital Management, LLC 0.40% 3,310,687 $15.4M
8 Diadema Partners LP 0.38% 476,424 $2.2M
9 Baker BROS. Advisors LP 0.29% 10,885,357 $50.5M
10 Armistice Capital, LLC 0.28% 3,398,000 $15.8M
11 Platinum Investment Management Ltd 0.22% 184,603 $857K
12 Persistent Asset Partners Ltd 0.21% 120,437 $559K
13 Siren, L.L.C. 0.20% 1,560,882 $7.2M
14 Palo Alto Investors LP 0.14% 201,890 $937K
15 EntryPoint Capital, LLC 0.09% 63,906 $297K
16 DAFNA Capital Management LLC 0.07% 64,492 $299K
17 Forefront Analytics, LLC 0.06% 14,394 $67K
18 R Squared Ltd 0.05% 21,057 $98K
19 Virtus Investment Advisers, LLC 0.05% 36,601 $170K
20 Eversept Partners, LP 0.05% 190,715 $885K
21 Axq Capital, LP 0.04% 63,134 $293K
22 Moore Capital Management, LP 0.03% 275,000 $1.3M
23 Portland Investment Counsel INC. 0.02% 15,000 $70K
24 ADAR1 Capital Management, LLC 0.02% 71,298 $331K
25 Silvercrest Asset Management Group LLC 0.01% 428,684 $2.0M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Bicycle Therapeutics plc (BCYC)

What does the Smart Money Trend signal show for BCYC?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their BCYC positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for BCYC?

Slight buying edge — 56% buying: Last quarter: 58 funds bought or added vs 45 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for BCYC holders?

Smaller funds dominant — 11% AUM from top-100: 23 of 96 holders rank in the top 100 by AUM, but together hold only 11% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held BCYC?

41% of holders stayed for 2+ years: 39 out of 96 hedge funds have held BCYC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Bicycle Therapeutics plc (BCYC) following the 2026 Q1 hedge fund 13F filings?

As of today, BCYC has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), BCYC has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →